✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAgingSafety Dr. Caplan’s Take “What we’re seeing with cannabinoids and hepatic steatosis is a genuine...
Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDHempSafety Why This Matters This research suggesting CBD and CBG may reduce hepatic steatosis and...
Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDMental HealthSafetyAnxiety Why This Matters Clinicians treating patients with nonalcoholic fatty liver disease currently lack...
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyCBDTHC Why This Matters Clinicians treating patients with non-alcoholic fatty liver disease (NAFLD) currently lack...
Study reveals cannabis compounds reduce threat of fatty liver disease | Health
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCSafety Why This Matters Clinicians should consider that cannabinoids may offer a novel therapeutic option...
Cannabis Compounds Exhibit Potential in Combatting Fatty Liver Disease
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCAging Why This Matters Clinicians managing patients with fatty liver disease now have preliminary evidence...
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – CBS19
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDTHCHemp Why This Matters This finding is clinically relevant because non-alcoholic fatty liver disease affects...
Drugs inhibiting cannabinoid receptor type-1 can reduce obesity-associated steatohepatitis
Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances In Summary: Steatohepatitis, a condition often associated with type 2 diabetes and...